Oral contraception, 1986. Endocrinology and pharmacology. A panel discussion.
D000328:Adult; D000818:Animals; D001943:Breast Neoplasms / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000139:chemically induced; D008076:Cholesterol, HDL / Q000378:metabolism; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D004334:Drug Administration Schedule; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D005833:Genital Neoplasms, Female / Q000517:prevention & control; D006801:Humans; D008656:Mestranol / Q000494:pharmacology; D008875:Middle Aged; D009640:Norethindrone / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D051381:Rats; D012306:Risk
D008076:Cholesterol, HDL; D003280:Contraceptives, Oral, Synthetic; D009644:Norgestrel; D004997:Ethinyl Estradiol; D008656:Mestranol; D009640:Norethindrone